Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001178913-24-000509
Filing Date
2024-02-14
Accepted
2024-02-14 06:05:19
Documents
3

Document Format Files

Seq Description Document Type Size
1 S-3/A zk2430951.htm S-3/A 381833
2 image0.jpg GRAPHIC 76115
3 image1.jpg GRAPHIC 84308
  Complete submission text file 0001178913-24-000509.txt   603908
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Filer) CIK: 0001638097 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-276844 | Film No.: 24631858
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)